↑ トップへ　← 戻る

 Drug（薬物リスト） DrugBank | All Description Patterns💬 Info on mouse-over

e.g. Sirolimus, アダリムマブ

ABCDEFGH I JKLMNOPQRSTUVWXYZother

333 / 17,542 descriptions

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY
On map, Yellow: Drug target genes		 指定難病告示番号
1 0.9% normal saline (control) - - - - 1件: 299 💬
2 0.9% sodium chloride (normal saline) Chloride ion 1件: D02056 💬 - - 1件:  6  💬
3 10% metronidazole ointment Metronidazole 3件: D00409, D05016, D05017 💬 - - 1件: 96 💬
4 19 nor vitamin d Vitamin D - - - 1件: 13 💬
5 : immunoglobulina umana normale 10% per somministrazione endovenosa - - - - 1件: 14 💬
6 [18f]-(e)-n-(3-iodoprop-2-enyl)-2b-carbofluoroethoxy-3b-(4'-methylphenyl)nortropane - - - - 1件:  6  💬
7 [18f]nos - - - - 1件:  6  💬
8 A novel synthetic, orally-administered, non-peptide small molecule, which acts as - - - - 1件: 254 💬
9 A-f-a-f (novorapid-fiasp-novorapid-fiasp) - - - - 1件: 299 💬
10 Administration of a high dose of desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件: 156 💬
11 Administration of a low dose of desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件: 156 💬
12 Administration of an ace-inhibitor or not - - - - 1件: 210 💬
13 Alk-001 (no generic name) - - - - 1件: 301 💬
14 Amikin, amiklin, amicacin, bb-k8, biklin, fabianol, kaminax, mikavir, novamin, pierami - - - - 1件: 299 💬
15 Amikin®, amiklin, amicacin, bb-k8, biklin®, fabianol®, kaminax, mikavir, novamin®, pierami - - - - 1件: 299 💬
16 Amlodipine Amlodipine 3件: D00615, D02914, D07450 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件: 51, 67, 298 💬
17 Amlodipine (drug) Amlodipine 3件: D00615, D02914, D07450 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 298 💬
18 Amlodipine gel Amlodipine 3件: D00615, D02914, D07450 💬 4件: CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 36件: Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 51 💬
19 Amoxicillin, metronidazole and tetracycline Amoxicillin 7件: D00201, D00229, D00409, D02925, D05016, D05017, D07452 💬 - - 1件: 97 💬
20 Atazanavir (atv) + ritonavir (rtv), continuation of backbone 2 nucleoside reverse transcriptase inhibitor (nrtis) Atazanavir 3件: D00427, D01276, D07471 💬 - - 1件: 265 💬
21 Atazanavir/ritonavir Atazanavir 3件: D00427, D01276, D07471 💬 - - 1件: 265 💬
22 Azithromycin + metronidazole Azithromycin 6件: D00409, D02134, D05016, D05017, D06390, D07486 💬 - - 1件: 96 💬
23 Aún no establecido - - - - 1件: 53 💬
24 Behavioral: assessment of motor and non-motors symptoms of pd evaluation of hyper- and hypodopaminergic behaviors - - - - 1件:  6  💬
25 Bia 9-1067 non-micronized BIA - - - 1件:  6  💬
26 Bio-enhanced curcumin soft gelatin capsule Curcumin 2件: D00115, D06892 💬 - - 1件: 97 💬
27 Biological : i10e (human normal immunoglobulin for intravenous administration 100mg/ml) Human immunoglobulin G - - - 1件: 14 💬
28 Biological: kiovig® (human normal immunoglobulin for intravenous administration 100mg/ml) Human immunoglobulin G - - - 1件: 14 💬
29 Botox 200u in normal saline - - - - 1件: 226 💬
30 Candesartan plus non-ccb agents Candesartan 1件: D00522 💬 1件: AGTR1 💬 16件: AGE-RAGE signaling pathway in diabetic complications, Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Apelin signaling pathway, Calcium signaling pathway, Coronavirus disease - COVID-19, Cortisol synthesis and secretion, Cushing syndrome, Diabetic cardiomyopathy, Neuroactive ligand-receptor interaction, Pathways in cancer, Phospholipase D signaling pathway, Renin secretion, Renin-angiotensin system, Vascular smooth muscle contraction, cGMP-PKG signaling pathway 1件: 67 💬
31 Cas no.: 7758-16-9 - - - - 1件: 166 💬
32 Catridecacog Catridecacog 1件: D10532 💬 - - 2件: 97, 288 💬
33 Celulas madre mesenquimales troncales adultas alogenicas de médula ósea no expandida - - - - 1件: 274 💬
34 Clarithromycin (not used as of 4/2020) Clarithromycin 1件: D00276 💬 - - 1件:  6  💬
35 Coenzyme q-10 in normal control subjects Ubidecarenone 1件: D01065 💬 - - 1件: 86 💬
36 Control intervention (no dexamethasone) Dexamethasone 9件: D00292, D00975, D01510, D01615, D01632, D01948, D02174, D02591, D02592 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 46 💬
37 Corticosteroid and non-biological agents. - - - - 1件: 46 💬
38 Cysteine Cysteine 2件: D00026, D02326 💬 - - 11件:  6 , 13, 19, 34, 84, 85, 88, 90, 254, 296, 310 💬
39 Cysteine hydrochloride Cysteine 2件: D00026, D02326 💬 - - 1件: 254 💬
40 Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas - - - - 1件: 274 💬
41 Células mesenquimales troncales adultas alogénicas de médula ósea no expandidas(ref cruzada pei nº 12-088) - - - - 1件: 274 💬
42 Ddavp (desmopressin) Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 288 💬
43 Desipramine Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 4件:  6 , 17, 120, 156 💬
44 Desipramine (dmi) Desipramine 2件: D00812, D07791 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 17 💬
45 Desmopressin Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 5件:  6 , 64, 72, 225, 288 💬
46 Desmopressin acetat Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件:  6  💬
47 Desmopressin acetate Acetate 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 2件: 64, 288 💬
48 Desmopressin acetate trihydrate Acetate 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 225 💬
49 Desmopressin intranasal Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 72 💬
50 Desmopressin oral melt Desmopressin 2件: D00291, D02235 💬 2件: AVPR2, F8 💬 4件: Complement and coagulation cascades, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 1件: 72 💬
51 Device: no orthosis - - - - 1件: 70 💬
52 Device: nocturnal oxygen , nocturnal bi-level positive pressure ventilation Oxygen 1件: D00003 💬 - - 1件: 299 💬
53 Device: non invasive ventilation - - - - 1件: 299 💬
54 Device: noninvasive ventilation - - - - 1件: 299 💬
55 Device: novel allergen-specific immune signature directed approach to dietary elimination therapy - - - - 1件: 98 💬
56 Device: occlusive non adherent dressing - - - - 1件: 36 💬
57 Device: reciprocating procedure device (rpd) - avanca re no. 1091001 - - - - 1件: 46 💬
58 Dexrazoxane (drz) plus mitoxantrone (mx) Dexrazoxane 3件: D02166, D03730, D08224 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 1件: 13 💬
59 Diagnostic test: nociceptor flexor reflex - - - - 1件: 149 💬
60 Droxidopa Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 3件:  5 ,  6 , 17 💬
61 Droxidopa 100 mg [northera] Droxidopa 1件: D01277 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件:  6  💬
62 Experimental (non immunosuppressive symptomatic treatment (nist) and rituximab) Rituximab 1件: D02994 💬 1件: MS4A1 💬 1件: Hematopoietic cell lineage 1件: 222 💬
63 Extavia (interferon beta-1b), novartis pharma ag Human interferon beta 1件: D00746 💬 2件: IFNAR1, IFNAR2 💬 18件: Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Epstein-Barr virus infection, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Measles, NOD-like receptor signaling pathway, Natural killer cell mediated cytotoxicity, Necroptosis, Osteoclast differentiation, PI3K-Akt signaling pathway, Pathways in cancer, Toll-like receptor signaling pathway 1件: 13 💬
64 Extended-release quetiapine fumarate Quetiapine 2件: D00458, D08456 💬 2件: DRD2, HTR2A 💬 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 1件: 13 💬
65 F-a-f-a (fiasp-novorapid-fiasp-novorapid) - - - - 1件: 299 💬
66 Freeze-dried sulfonated human normal immunoglobulin (ggs) Human immunoglobulin G - - - 3件: 14, 43, 45 💬
67 From august 2020 'no additional treatment' - - - - 1件: 51 💬
68 Ga-68-dota-noc - - - - 1件: 84 💬
69 Gallium68-dota-noc - - - - 1件: 85 💬
70 Gamma-secretase/notch signalling pathway inhibitor ro4929097 - - - - 1件: 74 💬
71 Gelatin Gelatin 2件: D00115, D06892 💬 - - 4件: 28, 78, 97, 269 💬
72 Ginger Ginger 1件: D06744 💬 - - 1件: 46 💬
73 Glatiramer acetate 20 mg, with mitoxantrone Acetate 3件: D02166, D04318, D08224 💬 22件: HLA-A, HLA-B, HLA-C, HLA-DMA, HLA-DMB, HLA-DOA, HLA-DOB, HLA-DPA1, HLA-DPB1, HLA-DQA1, HLA-DQA2, HLA-DQB1, HLA-DRA, HLA-DRB1, HLA-DRB3, HLA-DRB4, HLA-DRB5, HLA-E, HLA-F, HLA-G, TOP2A, TOP2B 💬 33件: Allograft rejection, Antigen processing and presentation, Asthma, Autoimmune thyroid disease, Cell adhesion molecules, Cellular senescence, Endocytosis, Epstein-Barr virus infection, Graft-versus-host disease, Hematopoietic cell lineage, Herpes simplex virus 1 infection, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Human papillomavirus infection, Inflammatory bowel disease, Influenza A, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Natural killer cell mediated cytotoxicity, Phagosome, Platinum drug resistance, Rheumatoid arthritis, Staphylococcus aureus infection, Systemic lupus erythematosus, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus, Viral carcinogenesis, Viral myocarditis 1件: 13 💬
74 Glucocorticoids (permitted,not necessary) - - - - 1件: 46 💬
75 Green tea leaf Green tea leaf 1件: D06903 💬 - - 1件: 17 💬
76 Gsk2018682 cd3 non-micronised tablet - - - - 1件: 13 💬
77 Gsk2018682 cd3 non-micronised tablet in fed state - - - - 1件: 13 💬
78 Hemin Hemin 1件: D10003 💬 2件: ALAS1, ALAS2 💬 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism 1件: 254 💬
79 Hemin for injection Hemin 1件: D10003 💬 2件: ALAS1, ALAS2 💬 4件: Biosynthesis of cofactors, Glycine, serine and threonine metabolism, Metabolic pathways, Porphyrin and chlorophyll metabolism 1件: 254 💬
80 Human normal 10% immunoglobulin for intravenous administration - - - - 1件: 14 💬
81 Human normal 10% immunoglobulin for intravenous administrationn - - - - 1件: 14 💬
82 Human normal immunoglobulin Human immunoglobulin G - - - 9件: 11, 13, 14, 43, 45, 50, 51, 63, 65 💬
83 Human normal immunoglobulin (iv) Human immunoglobulin G - - - 4件: 11, 14, 63, 65 💬
84 Human normal immunoglobulin (ivig) Human immunoglobulin G - - - 2件: 50, 65 💬
85 Human normal immunoglobulin (scig) Human immunoglobulin G - - - 1件: 14 💬
86 Human normal immunoglobulin (subcutaneous - intramuscular immunoglobulin) Human immunoglobulin G - - - 1件: 65 💬
87 Human normal immunoglobulin (subcutaneous) Human immunoglobulin G - - - 1件: 65 💬
88 Human normal immunoglobulin for Human immunoglobulin G - - - 1件: 65 💬
89 Human normal immunoglobulin for intravenous (iv) administration Human immunoglobulin G - - - 1件: 51 💬
90 Human normal immunoglobulin for intravenous administration Human immunoglobulin G - - - 3件: 14, 51, 65 💬
91 Human normal immunoglobulin for intravenous use Human immunoglobulin G - - - 2件: 63, 65 💬
92 Human normal immunoglobulin for intravenous use (ivig) Human immunoglobulin G - - - 1件: 65 💬
93 Human normal immunoglobulin for intrvenous use Human immunoglobulin G - - - 1件: 63 💬
94 Human normal immunoglobulin for subcutaneous administration Human immunoglobulin G - - - 2件: 51, 65 💬
95 Human normal immunoglobulin for subcutaneous administration (igsc) Human immunoglobulin G - - - 1件: 65 💬
96 Human normal immunoglobulin g (igg > 98% purity) Human immunoglobulin G - - - 3件: 14, 63, 65 💬
97 Human normal immunoglobulin g (igg) Human immunoglobulin G - - - 1件: 11 💬
98 Human normal immunoglogulin (ivig) Human immunoglobulin G - - - 1件: 50 💬
99 Human recombinant tissue non-specific alkaline phosphatase fusion protein Alkaline Phosphatase - - - 1件: 172 💬
100 Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy - - - - 1件:  2  💬
101 Immunoglobulin g1, anti (protein nogo a) (human mus musculus monoclonal heavy chain), disulfide with human mus musculus monoclonal light chain, dimer - - - - 1件:  2  💬
102 Immunoglobulina umana normale per somministrazione endovenosa - - - - 1件: 14 💬
103 Immunoglobulins, normal human - - - - 1件: 65 💬
104 Immunoglobulins, normal human, for extravascular adm. - - - - 1件: 14 💬
105 Immunoglobulins, normal human, for intravascular adm. - - - - 2件: 14, 15 💬
106 Inhaled nitric oxide Nitric Oxide 1件: D00074 💬 - - 2件: 85, 86 💬
107 Inhaled nitric oxide & inopulse delivery Nitric Oxide 1件: D00074 💬 - - 1件: 86 💬
108 Inhaled nitric oxide - 30 mcg/kg ibw/hr Nitric Oxide 1件: D00074 💬 - - 1件: 85 💬
109 Inhaled nitric oxide 5,10,15 mcg/kg ibw/hr Nitric Oxide 1件: D00074 💬 - - 1件: 85 💬
110 Inhaled nitric oxide 75 mcg/kg ibw/hr Nitric Oxide 1件: D00074 💬 - - 2件: 85, 86 💬
111 Inhaled no with pulsed delivery - - - - 1件: 86 💬
112 Injection of normal saline - - - - 1件:  6  💬
113 Inn not available - - - - 2件: 19, 46 💬
114 Inn not available yet - - - - 1件: 222 💬
115 Inn not yet proposed - - - - 1件: 193 💬
116 Intravenous and oral n-acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 1件:  6  💬
117 Istradefylline Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
118 Istradefylline ( kw-6002) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
119 Istradefylline (kw-6002) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
120 Istradefylline 20 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
121 Istradefylline 20 mg or 40 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
122 Istradefylline 40 mg Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
123 Kw-6002 (istradefylline) Istradefylline 1件: D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
124 Leflunomide (permitted, not necessary) Leflunomide 1件: D00749 💬 1件: DHODH 💬 3件: Biosynthesis of cofactors, Metabolic pathways, Pyrimidine metabolism 1件: 46 💬
125 Lenadogene nolparvovec - - - - 1件: 302 💬
126 Levobupivacaine Levobupivacaine 2件: D01287, D08116 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 46 💬
127 Levonorgestrel Levonorgestrel 1件: D00950 💬 1件: PGR 💬 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 1件: 13 💬
128 Loestrin (norethindrone acetate and ethinyl estradiol) Acetate 11件: D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬 3件: ESR1, ESR2, PGR 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 299 💬
129 Loestrin 1.5/30 (1.5 mg norethindrone acetate/30 µg ethinyl estradiol) Acetate 11件: D00105, D00182, D00554, D00953, D01413, D01617, D01953, D04061, D04063, D04064, D04065 💬 3件: ESR1, ESR2, PGR 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 2件: 46, 49 💬
130 Lopinavir/ritonavir Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
131 Lopinavir/ritonavir + nevirapine Lopinavir 3件: D00427, D00435, D01425 💬 - - 1件: 265 💬
132 Lopinavir/ritonavir + zidovudine + lamivudine Lamivudine 4件: D00353, D00413, D00427, D01425 💬 - - 1件: 265 💬
133 Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
134 Methotrexate(mtx) administration is at the discretion of the rheumatologist and no tradename is fixed by the protocol. Methotrexate 2件: D00142, D02115 💬 2件: DHFR, DHFR2 💬 5件: Antifolate resistance, Biosynthesis of cofactors, Folate biosynthesis, Metabolic pathways, One carbon pool by folate 1件: 46 💬
135 Metronidazole Metronidazole 3件: D00409, D05016, D05017 💬 - - 8件: 46, 51, 63, 94, 95, 96, 97, 291 💬
136 Metronidazole capsule 50 mg Metronidazole 3件: D00409, D05016, D05017 💬 - - 1件: 97 💬
137 Mitoxantrone Mitoxantrone 2件: D02166, D08224 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 1件: 13 💬
138 Monotherapy (lopinavir/ritonavir) Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
139 Monotherapy (lopinavir/ritonavir) + abc/3tc Lopinavir 2件: D00427, D01425 💬 - - 1件: 265 💬
140 N acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 2件:  6 , 19 💬
141 N-acetyl cysteine Cysteine 2件: D00026, D02326 💬 - - 7件: 13, 19, 34, 85, 88, 296, 310 💬
142 N-acetyl cysteine (nac) Cysteine 2件: D00026, D02326 💬 - - 1件: 90 💬
143 N-acetyl-cysteine Cysteine 2件: D00026, D02326 💬 - - 1件: 84 💬
144 Neoral soft gelatin capsules Gelatin 2件: D00115, D06892 💬 - - 2件: 97, 269 💬
145 Nitric oxide Nitric Oxide 1件: D00074 💬 - - 8件: 46, 85, 86, 98, 210, 251, 294, 299 💬
146 Nitric oxide 160 ppm Nitric Oxide 1件: D00074 💬 - - 1件: 299 💬
147 Nitric oxide for inhalation Nitric Oxide 1件: D00074 💬 - - 2件: 86, 299 💬
148 Nitric oxide generated by the geno nitrosyl delivery system Nitric Oxide 1件: D00074 💬 - - 1件: 86 💬
149 Nitric oxide plus oxygen Nitric Oxide 2件: D00003, D00074 💬 - - 1件: 86 💬
150 Nitric oxide supplement Nitric Oxide 1件: D00074 💬 - - 1件: 251 💬
151 No - - - - 3件: 46, 62, 299 💬
152 Nolpitantium besylate - - - - 1件: 97 💬
153 Nomegestrol Nomegestrol 1件: D07222 💬 1件: PGR 💬 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 1件: 13 💬
154 Nomegestrol acetate Acetate 2件: D07222, D08281 💬 1件: PGR 💬 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 1件: 13 💬
155 Non applicabile - - - - 1件: 51 💬
156 Non applicable - - - - 2件: 10, 19 💬
157 Non as of yet - - - - 1件: 97 💬
158 Non atg conditioning regimen - - - - 1件: 60 💬
159 Non propietry, therefore n/a - - - - 1件: 51 💬
160 Non-anti-tnf biologics - - - - 2件: 46, 271 💬
161 Non-biologic anti-rheumatic drugs - - - - 1件: 46 💬
162 Non-biologic disease modifying anti-rheumatic drug (dmard) - - - - 1件: 46 💬
163 Non-biologic dmards - - - - 2件: 46, 86 💬
164 Non-biological dmard's - - - - 1件: 46 💬
165 Non-biological dmards - - - - 1件: 46 💬
166 Non-myeloablative hematopoietic stem cell transplantation - - - - 1件: 93 💬
167 Non-nucleoside reverse transcriptase inhibitors - - - - 1件: 265 💬
168 Non-pegylated interferon - - - - 1件: 13 💬
169 Non-steroidal anti-inflammatory drug - - - - 1件: 46 💬
170 Non-steroidal anti-inflammatory drug (nsaid) - - - - 1件: 46 💬
171 Non-steroidal anti-inflammatory drugs - - - - 1件: 46 💬
172 Non-steroidal anti-inflammatory drugs (nsaids) - - - - 1件: 107 💬
173 Nonbiologic dmards of investigator's choice - - - - 1件: 46 💬
174 None - - - - 14件: 46, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 💬
175 None as of yet - - - - 1件: 46 💬
176 None assigned - - - - 2件: 231, 299 💬
177 None at this time - - - - 2件: 96, 140 💬
178 None given - - - - 1件: 97 💬
179 Nordiflex - - - - 1件: 78 💬
180 Nordilet® - - - - 1件: 78 💬
181 Norditropin - - - - 1件: 78 💬
182 Norditropin 24 iu - - - - 1件: 195 💬
183 Norditropin flexpro 10 mg - - - - 1件: 78 💬
184 Norditropin flexpro 10 mg/1.5 ml - - - - 1件: 78 💬
185 Norditropin growth hormone Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
186 Norditropin nordiflex® - - - - 1件: 78 💬
187 Norditropin nordiflex® 10 mg/1.5 ml - - - - 1件: 78 💬
188 Norditropin nordiflex® 10mg/1.5 ml - - - - 1件: 78 💬
189 Norditropin simplex - - - - 1件: 78 💬
190 Norditropin simplexx - - - - 4件:  3 , 78, 193, 195 💬
191 Norditropin simplexx (5mg/1,5 ml) (inn:somatropin) Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
192 Norditropin simplexx (growth hormone) Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
193 Norditropin simplexx 10 mg - - - - 1件: 78 💬
194 Norditropin simplexx 15 mg/1.5 ml - - - - 1件:  3  💬
195 Norditropin simplexx 5mg/1.5ml - - - - 1件: 78 💬
196 Norditropin® - - - - 1件: 78 💬
197 Norditropin® flexpro® - - - - 1件: 78 💬
198 Norditropin® flexpro® pen - - - - 1件: 78 💬
199 Norditropin® simplexx® 5 mg/1.5ml - - - - 1件: 78 💬
200 Norepinephrine Norepinephrine 2件: D00076, D05206 💬 9件: ADRA1A, ADRA1B, ADRA1D, ADRA2A, ADRA2B, ADRA2C, ADRB1, ADRB2, ADRB3 💬 13件: AMPK signaling pathway, Adrenergic signaling in cardiomyocytes, Calcium signaling pathway, Dilated cardiomyopathy, Gap junction, Neuroactive ligand-receptor interaction, Regulation of lipolysis in adipocytes, Renin secretion, Salivary secretion, Thermogenesis, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 1件: 22 💬
201 Norethindrone Norethisterone 2件: D00182, D00953 💬 1件: PGR 💬 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 4件: 13, 46, 49, 299 💬
202 Norgestimate Norgestimate 1件: D05209 💬 1件: PGR 💬 4件: Breast cancer, Estrogen signaling pathway, Oocyte meiosis, Progesterone-mediated oocyte maturation 1件: 299 💬
203 Normal human immunoglobulin g Human immunoglobulin G - - - 1件: 65 💬
204 Normal saline - - - - 16件:  6 , 17, 22, 36, 46, 49, 60, 70, 94, 96, 210, 211, 226, 276, 296, 299 💬
205 Normal saline 0.9% infusion solution - - - - 1件: 22 💬
206 Normal saline enema - - - - 1件: 97 💬
207 Normal saline for injection - - - - 1件: 13 💬
208 Normal saline instillation - - - - 1件: 226 💬
209 Normal saline iv, salt tablets - - - - 1件: 299 💬
210 Normal saline solution - - - - 1件: 299 💬
211 Normal saline: - - - - 1件: 299 💬
212 Normix - - - - 1件: 96 💬
213 Normix*ad 12cpr riv 200mg - - - - 1件: 96 💬
214 Norspan - - - - 1件: 46 💬
215 Northera - - - - 1件:  6  💬
216 Nortriptyline Nortriptyline 2件: D00816, D08288 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 2件:  6 , 226 💬
217 Nortriptyline hydrochloride Nortriptyline 2件: D00816, D08288 💬 2件: SLC6A2, SLC6A4 💬 2件: Serotonergic synapse, Synaptic vesicle cycle 1件:  6  💬
218 Norudca - - - - 1件: 94 💬
219 Norursodeoxycholic acid norUrsodeoxycholic acid - - - 1件: 94 💬
220 Norvir - - - - 2件: 265, 299 💬
221 Norvir 100 mg film-coated tablets - - - - 1件: 299 💬
222 Novamin - - - - 1件: 299 💬
223 Novantrone - - - - 1件: 13 💬
224 Novantrone*inf 2mg/ml 5ml - - - - 1件: 13 💬
225 Novartis pharmaceuticals corporation - - - - 1件: 13 💬
226 Novatrex - - - - 1件: 13 💬
227 Novo rapid - - - - 1件: 299 💬
228 Novo rapid insulin (novonordisk) - - - - 1件: 299 💬
229 Novolin-r insulin - - - - 1件: 127 💬
230 Novolog insulin - - - - 1件: 299 💬
231 Novonorm 0.5 mg - - - - 1件: 299 💬
232 Novonorm 1 mg - - - - 1件: 299 💬
233 Novonorm 2 mg - - - - 1件: 299 💬
234 Novorapid / humalog short acting insulin - - - - 1件: 299 💬
235 Novorapid 100 u/ml, solution for injection in a vial. novorapid penfill 100 u/ml, solution for injection in a cartridge. novorapid flexpen 100 u/ml, solution for injection in a pre-filled pen. - - - - 1件: 299 💬
236 Novorapid aspartate - - - - 1件: 299 💬
237 Nox-e36 - - - - 1件: 49 💬
238 Noxafil - - - - 3件: 60, 65, 299 💬
239 Noxafil - 40 mg/ml sospensione orale uso orale flacone (vetro) 105 ml 1 flacone - - - - 1件: 299 💬
240 Noxafil - oral suspension 40 mg/ml - - - - 1件: 299 💬
241 Noxafil 100 mg - - - - 1件: 299 💬
242 Noxafil 40 mg/ml oral solution - - - - 1件: 65 💬
243 Noxafil gastro resistant tablets - - - - 1件: 60 💬
244 Noxafil® - - - - 2件: 60, 299 💬
245 Nsaids (permitted,not necessary) - - - - 1件: 46 💬
246 Ortho-cyclen, ethinyl estradiol/norgestimate, 0.035 mg/0.250 mg Estradiol 10件: D00105, D00554, D01413, D01617, D01953, D04061, D04063, D04064, D04065, D05209 💬 3件: ESR1, ESR2, PGR 💬 11件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Progesterone-mediated oocyte maturation, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 299 💬
247 Ortho-novum - - - - 2件: 46, 49 💬
248 Ortho-novum 777 - - - - 1件: 49 💬
249 Ortho-novum® 1/35 - - - - 1件: 46 💬
250 Other non steroidal anti-inflammatory drugs (nsaids) except etodolac Etodolac 1件: D00315 💬 1件: PTGS2 💬 22件: Alzheimer disease, Arachidonic acid metabolism, C-type lectin receptor signaling pathway, Chemical carcinogenesis, Human cytomegalovirus infection, Human papillomavirus infection, IL-17 signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Metabolic pathways, MicroRNAs in cancer, NF-kappa B signaling pathway, Ovarian steroidogenesis, Oxytocin signaling pathway, Pathways in cancer, Pathways of neurodegeneration - multiple diseases, Regulation of lipolysis in adipocytes, Retrograde endocannabinoid signaling, Serotonergic synapse, Small cell lung cancer, TNF signaling pathway, VEGF signaling pathway 1件: 46 💬
251 Other non-selective nsaids - - - - 1件: 271 💬
252 Other non-sponsor pancreatic enzyme replacement therapy - - - - 1件: 299 💬
253 Other: antigen (wheat base soy sauce) spray Wheat 1件: D06902 💬 - - 1件: 98 💬
254 Other: control group(normal saline) - - - - 1件: 97 💬
255 Other: dietary intervention with no-carrageenan diet - - - - 1件: 97 💬
256 Other: fractional exhaled no (feno) - - - - 1件: 96 💬
257 Other: mitoxantrone - immunomodulator Mitoxantrone 2件: D02166, D08224 💬 2件: TOP2A, TOP2B 💬 1件: Platinum drug resistance 1件: 13 💬
258 Other: no active treatment - - - - 1件: 274 💬
259 Other: no anti-inflammatory treatment - - - - 1件: 271 💬
260 Other: no device - - - - 1件: 13 💬
261 Other: no doxycycline Doxycycline 5件: D00307, D02129, D03903, D03904, D07876 💬 - - 1件: 299 💬
262 Other: no enzyme therapy - - - - 1件: 298 💬
263 Other: no intervention - - - - 1件: 70 💬
264 Other: no intervention: standard of care - - - - 1件: 85 💬
265 Other: no it treatment - - - - 1件: 19 💬
266 Other: no msdmds therapy (control) - - - - 1件: 13 💬
267 Other: no pancreatic enzyme replacement therapy - - - - 1件: 299 💬
268 Other: no plasma exchange - - - - 2件: 43, 44 💬
269 Other: no treatment - - - - 2件: 53, 256 💬
270 Other: no treatment arm - - - - 1件: 13 💬
271 Other: no treatment given - - - - 1件: 78 💬
272 Other: non impact aerobics - - - - 1件: 13 💬
273 Other: non-hormonal period - - - - 1件: 299 💬
274 Other: non-motor symptoms - - - - 1件:  6  💬
275 Other: noninvasive actigraphy monitor Methamidophos - - - 1件: 86 💬
276 Other: nordic walking (only osteoporosis group) - - - - 1件:  6  💬
277 Other: normal (control) diet - - - - 1件: 240 💬
278 Other: normal diet - - - - 1件: 96 💬
279 Other: normal saline - - - - 4件: 13, 222, 226, 280 💬
280 Other: normal saline for injection - - - - 1件: 84 💬
281 Other: oral nitric oxide testing Nitric Oxide 1件: D00074 💬 - - 1件: 98 💬
282 Other: sham (no implant) - - - - 1件: 90 💬
283 Other: sterile normal saline (0.9% nacl) - - - - 1件: 231 💬
284 Other: wheat flour Wheat 1件: D06902 💬 - - 1件: 266 💬
285 Patients' existing non-steroidal anti-inflammatory drug (nsaid) at approved doses - - - - 1件: 46 💬
286 Pk-merz® 200mg/500ml inj(amantadine) , normal saline 500ml inj Amantadine 2件: D00777, D07441 💬 5件: GRIN1, GRIN2A, GRIN2B, GRIN2C, GRIN2D 💬 20件: Alcoholism, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Calcium signaling pathway, Circadian entrainment, Cocaine addiction, Dopaminergic synapse, Glutamatergic synapse, Huntington disease, Long-term potentiation, Neuroactive ligand-receptor interaction, Nicotine addiction, Pathways of neurodegeneration - multiple diseases, Prion disease, Rap1 signaling pathway, Ras signaling pathway, Spinocerebellar ataxia, Systemic lupus erythematosus, cAMP signaling pathway 1件:  6  💬
287 Posaconazole Posaconazole 1件: D02555 💬 - - 3件: 60, 65, 299 💬
288 Posaconazole (psz) Posaconazole 1件: D02555 💬 - - 1件: 65 💬
289 Prednison 5, 20 léciva por. tablet nob - - - - 1件: 50 💬
290 Prednison 5, 20 léciva por. tablet nob. - - - - 1件: 50 💬
291 Procedure: alcohol wipes vs. no alcohol wipes Ethanol 4件: D00068, D02798, D04855, D06542 💬 - - 1件: 13 💬
292 Procedure: audiological and ear, nose and throat examination - - - - 1件: 78 💬
293 Procedure: exhaled nitric oxide Nitric Oxide 1件: D00074 💬 - - 1件: 299 💬
294 Procedure: exhaled nitric oxide assessment Nitric Oxide 1件: D00074 💬 - - 1件: 46 💬
295 Procedure: iv deployment of csvf in sterile normal saline iv solution - - - - 2件: 85, 229 💬
296 Procedure: large bore (19g) histologic needle biopsy of the mediastinal lymph nodes - - - - 1件: 84 💬
297 Procedure: no celiac block - - - - 1件: 298 💬
298 Procedure: no gas - - - - 2件: 86, 88 💬
299 Procedure: non-myeloablative high dose immunosuppressive therapy conditioning (hdit) - - - - 1件: 49 💬
300 Procedure: nonmyeloablative allogeneic hematopoietic stem cell transplantation - - - - 6件: 28, 51, 60, 62, 65, 285 💬
301 Quetiapine Quetiapine 2件: D00458, D08456 💬 2件: DRD2, HTR2A 💬 11件: Alcoholism, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Serotonergic synapse, cAMP signaling pathway 2件:  6 , 13 💬
302 Rebif new formulation non titrated - - - - 1件: 13 💬
303 Recombinant human somatotropin Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 2件: 78, 236 💬
304 Regular novolin r - - - - 1件:  6  💬
305 Rhgh norditropin® flexpro® pen (34 µg/kg) Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 1件: 78 💬
306 Rifampicin Rifampicin 1件: D00211 💬 - - 5件:  6 , 17, 46, 93, 299 💬
307 Rifampin 300mg bid + istradefylline 40mg day 8 only Istradefylline 2件: D00211, D04641 💬 1件: ADORA2A 💬 7件: Alcoholism, Calcium signaling pathway, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, Vascular smooth muscle contraction, cAMP signaling pathway 1件:  6  💬
308 Ritonavir Ritonavir 1件: D00427 💬 - - 3件:  2 , 86, 265 💬
309 Ritonavir (norvir) Ritonavir 1件: D00427 💬 - - 1件: 265 💬
310 Rokan (r) novo 120 mg - - - - 1件: 18 💬
311 Ropivacaine plus normal saline Ropivacaine 2件: D04048, D08490 💬 5件: SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 3件: Adrenergic signaling in cardiomyocytes, Dopaminergic synapse, Taste transduction 1件: 70 💬
312 Saquinavir and ritonavir Ritonavir 3件: D00427, D00429, D01160 💬 - - 1件: 86 💬
313 Sativex oromucosal spray (non-marketed) - - - - 1件: 13 💬
314 Somatotropin Somatotropin 1件: D02691 💬 1件: GHR 💬 5件: Cytokine-cytokine receptor interaction, Growth hormone synthesis, secretion and action, JAK-STAT signaling pathway, Neuroactive ligand-receptor interaction, PI3K-Akt signaling pathway 3件:  3 , 78, 236 💬
315 Sterile normal saline (0.9% nacl) - - - - 3件: 62, 234, 254 💬
316 Sterile normal saline for intravenous use - - - - 2件: 85, 229 💬
317 Systemic non-biological treatments - - - - 2件: 46, 271 💬
318 Tafamidis meglumine 20 mg soft gelatin capsules Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
319 Tafamidis meglumine 20mg soft gelatin capsule (clinical trial image) Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
320 Tafamidis meglumine 20mg soft gelatin capsule (commerical image) Gelatin 4件: D00115, D01796, D06892, D09673 💬 1件: TTR 💬 1件: Thyroid hormone synthesis 1件: 28 💬
321 Takecab tablets + amoxicillin + clarithromycin (first-line eradication) takecab tablets + amoxicillin + metronidazole (second-line eradication) Amoxicillin 7件: D00229, D00276, D00409, D02925, D05016, D05017, D07452 💬 - - 1件: 63 💬
322 Tamoxifen Tamoxifen 2件: D00966, D08559 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 4件:  2 , 86, 113, 227 💬
323 Tamoxifen 20mg hexal® filmtabletten Tamoxifen 2件: D00966, D08559 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 113 💬
324 Tamoxifen 40 mg daily for one year Tamoxifen 2件: D00966, D08559 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件:  2  💬
325 Tamoxifen citrate Tamoxifen 2件: D00966, D08559 💬 2件: ESR1, ESR2 💬 9件: Breast cancer, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Pathways in cancer, Prolactin signaling pathway, Proteoglycans in cancer, Thyroid hormone signaling pathway 1件: 113 💬
326 The investigational medicinal product (imp) may be labelled as either pf-04236921 106 mg/vial, clonal sc lyophilized form” or pf-04236921 powder for injection, 106 mg/vial”. supplies labelled with either nomenclature are equivalent. - - - - 1件: 96 💬
327 There is no recommended inn - - - - 1件: 65 💬
328 Tnf-a antagonists, non-tnfs, dmard non-biologics - - - - 2件: 46, 271 💬
329 Topotecan Topotecan 2件: D02168, D08618 💬 - - 1件: 25 💬
330 Triamcinolone acetonide and normal saline solution Triamcinolone 5件: D00385, D00983, D00984, D00985, D06216 💬 1件: NR3C1 💬 1件: Neuroactive ligand-receptor interaction 1件: 70 💬
331 Ustekinumab iv - nonresponder - ustekinumab 90mg sc (mp) Ustekinumab 1件: D09214 💬 3件: IL12A, IL12B, IL23A 💬 26件: African trypanosomiasis, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 1件: 96 💬
332 Wheat Wheat 1件: D06902 💬 - - 2件: 98, 266 💬
333 Zofran - no intubation - - - - 1件: 98 💬

先頭へ